Patient-derived cancer cell lines could address two major challenges in oncology: real-time drug response prediction and the creation of massive knowledge banks. A new study showcases the power of this approach for precision oncology.
This is a preview of subscription content, log in via an institution to check access.
References
Hutter, C. & Zenklusen, J. C. Cell 173, 283–285 (2018).
Sanchez-Vega, F. et al. Cell 173, 321–337 (2018).
Iorio, F. et al. Cell 166, 740–754 (2016).
Lee, J.-K. et al. Nat. Genet. https://doi.org/10.1038/s41588-018-0209-6 (2018).
van de Wetering, M. et al. Cell 161, 933–945 (2015).
Vlachogiannis, G. et al. Science 359, 920–926 (2018).
Lee, S. H. et al. Cell 173, 515–528 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
McDermott, U. Cancer cell lines as patient avatars for drug response prediction. Nat Genet 50, 1350–1351 (2018). https://doi.org/10.1038/s41588-018-0245-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-018-0245-2
- Springer Nature America, Inc.